PD30 - Management of pediatric anaphylaxis - comparison between a district general hospital (DGH) and a regional centre in UK by Srinivas Jyothi et al.
POSTER DISCUSSION PRESENTATION Open Access
PD30 - Management of pediatric anaphylaxis -
comparison between a district general hospital
(DGH) and a regional centre in UK
Srinivas Jyothi1*, Georgina Harlow2, Anand Kanani1, Manju Kannath1, Arun Ghose1, Julia Richardson2,
Nicola Dowling2, Nick Makwana2
From 3rd Pediatric Allergy and Asthma Meeting (PAAM)
Athens, Greece. 17-19 October 2013
Background
Anaphylaxis is a serious, life-threatening hypersensitivity
reaction. The incidence of anaphylaxis is 4-5 per 100,000
persons per year and is reported to be increasing in recent
years.
Aims
We analysed management of suspected anaphylaxis in
children at a DGH and a regional referral center in UK.
Methods
A retrospective case note analysis was carried out between
January 2007 and September 2012, which was compared to
NICE (National Institute of Clinical Excellence) guidelines.
Results
We identified a total of 81 cases from the DGH of which
71 case notes were analysed and a total of 30 cases from
the regional centre.
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Table 1 Initial management
Initial Management Percentage of children who received intervention (%)
DGH Regional centre





Nebulised salbutamol 76 40
Table 2 Compliance with NICE guidelines on discharge
On discharge Percentage of children (%)
DGH Regional centre
Allergy clinic follow up planned 92 54
Issued with adrenaline auto injector 69 10
Documented training in auto injector use if given 73 13
Patients receiving discharge information about anaphylaxis 73 23
Patients receiving discharge information fulfilling the criteria stated by NICE 0 0
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Both centers’ were good at documenting acute clinical
features (>95%) and the circumstances prior to symptom
onset (>93%). Both hospitals need to improve their docu-
mentation of time of onset of reaction (50:30%), informing
about biphasic reaction (8.5- 1%) and supply information
regarding support groups (1.4-0%). Our study revealed
no child received full discharge information according
to NICE criteria.
The DGH performed better than the tertiary center in
referral to specialist allergy services providing adrenaline
auto injector and demonstration of auto injector.
Conclusions
The DGH outperformed the tertiary center likely due to
availability of specialist allergy services. We endeavor to
improve our management by establishment of specialist
allergy services at the tertiary hospital and anaphylaxis
education among all doctors.
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